Simplex Trading, LLC Cogent Biosciences, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$4.38 - $9.02 $31,987 - $65,873	7,303 New	7,303 $49,000
Q3 2023 Nov 01, 2023	BUY	$9.69 - $13.34 $25,475 - $35,070	2,629 New	2,629 $25,000
Q1 2023 Apr 27, 2023	SELL	$10.04 - $15.5 $12,549 - $19,375	-1,250 Reduced 64.8%	679 $7,000
Q4 2022 Feb 02, 2023	SELL	$10.65 - $14.84 $38,595 - $53,780	-3,624 Reduced 65.26%	1,929 $22,000
Q3 2022 Nov 04, 2022	BUY	$9.39 - $16.99 $52,142 - $94,345	5,553 New	5,553 $82,000
Q1 2022 May 02, 2022	SELL	$5.31 - $8.7 $531 - $869	-100 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$7.51 - $10.81 $751 - $1,081	100 New	100 $0

172

114M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $612M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.